Prestige Biologics Financials
| 334970 Stock | KRW 5,200 100.00 1.89% |
Prestige |
Understanding current and past Prestige Biologics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Prestige Biologics' financial statements are interrelated, with each one affecting the others. For example, an increase in Prestige Biologics' assets may result in an increase in income on the income statement.
Please note, the presentation of Prestige Biologics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Prestige Biologics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Prestige Biologics' management manipulating its earnings.
Prestige Biologics Stock Summary
Prestige Biologics competes with Samsung Biologics, SK Bioscience, Green Cross, MedPacto, and Prestige Biologics. Prestige Biologics Co., Ltd. specializes in the development and production of biologic agents and biosimilars. The company was founded in 2015 and is based in Cheongju-si, South Korea. Prestige Biologics is traded on Korean Securities Dealers Automated Quotations in South Korea.| Instrument | Korea Stock View All |
| Exchange | KOSDAQ |
| Business Address | 197, Osongsaengmyeong 1-ro, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | pbpharma.co.kr |
| Phone | 82 4 3232 1552 |
| Currency | KRW - South Korean Won |
You should never invest in Prestige Biologics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Prestige Stock, because this is throwing your money away. Analyzing the key information contained in Prestige Biologics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Prestige Biologics Key Financial Ratios
Prestige Biologics' financial ratios allow both analysts and investors to convert raw data from Prestige Biologics' financial statements into concise, actionable information that can be used to evaluate the performance of Prestige Biologics over time and compare it to other companies across industries.Prestige Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Prestige Biologics's current stock value. Our valuation model uses many indicators to compare Prestige Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Prestige Biologics competition to find correlations between indicators driving Prestige Biologics's intrinsic value. More Info.Prestige Biologics Co is rated below average in return on equity category among its peers. It is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Prestige Biologics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Prestige Biologics' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Prestige Biologics Systematic Risk
Prestige Biologics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Prestige Biologics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Prestige Biologics correlated with the market. If Beta is less than 0 Prestige Biologics generally moves in the opposite direction as compared to the market. If Prestige Biologics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Prestige Biologics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Prestige Biologics is generally in the same direction as the market. If Beta > 1 Prestige Biologics moves generally in the same direction as, but more than the movement of the benchmark.
Prestige Biologics December 18, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Prestige Biologics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Prestige Biologics Co. We use our internally-developed statistical techniques to arrive at the intrinsic value of Prestige Biologics Co based on widely used predictive technical indicators. In general, we focus on analyzing Prestige Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Prestige Biologics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 22.64 | |||
| Value At Risk | (6.33) | |||
| Potential Upside | 6.13 |
Complementary Tools for Prestige Stock analysis
When running Prestige Biologics' price analysis, check to measure Prestige Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prestige Biologics is operating at the current time. Most of Prestige Biologics' value examination focuses on studying past and present price action to predict the probability of Prestige Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prestige Biologics' price. Additionally, you may evaluate how the addition of Prestige Biologics to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |